Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion type Assertion NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_head.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion description "[The highest odds ratios (ORs) for the associations were observed between the homozygous variant genotype XRCC1 Gln399Gln and the risk of glioma (OR = 1.32; 95% confidence interval, CI, 0.97-1.81), glioblastoma (OR = 1.48; 95% CI, 0.98-2.24), and meningioma (OR = 1.34; 95% CI, 0.96-1.86).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_provenance.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion evidence source_evidence_literature NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_provenance.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion SIO_000772 18330515 NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_provenance.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion wasDerivedFrom befree-20140225 NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_provenance.
- NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_assertion wasGeneratedBy ECO_0000203 NP476172.RAt-meHwWcLxncmKRUq4GPOgddDCHwSL4Uk5g24-p7aDE130_provenance.